Annual Shareholders Equity
$206.58 M
+$45.56 M+28.29%
30 April 2024
Summary:
KalVista Pharmaceuticals annual stockholders equity is currently $206.58 million, with the most recent change of +$45.56 million (+28.29%) on 30 April 2024. During the last 3 years, it has fallen by -$50.61 million (-19.68%). KALV annual shareholders equity is now -19.68% below its all-time high of $257.19 million, reached on 30 April 2021.KALV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$172.80 M
-$33.78 M-16.35%
31 July 2024
Summary:
KalVista Pharmaceuticals quarterly stockholders equity is currently $172.80 million, with the most recent change of -$33.78 million (-16.35%) on 31 July 2024. Over the past year, it has increased by +$58.35 million (+50.99%). KALV quarterly shareholders equity is now -32.81% below its all-time high of $257.19 million, reached on 30 April 2021.KALV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALV Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.3% | +51.0% |
| 3 y3 years | -19.7% | -24.0% |
| 5 y5 years | +113.5% | +76.7% |
KALV Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.7% | +28.3% | -24.0% | +95.1% |
| 5 y | 5 years | -19.7% | +146.7% | -32.8% | +195.1% |
| alltime | all time | -19.7% | +567.6% | -32.8% | +452.9% |
KalVista Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $172.80 M(-16.4%) |
| Apr 2024 | $206.58 M(+28.3%) | $206.58 M(+133.2%) |
| Jan 2024 | - | $88.58 M(-22.6%) |
| Oct 2023 | - | $114.45 M(-17.9%) |
| July 2023 | - | $139.34 M(-13.5%) |
| Apr 2023 | $161.03 M(-13.0%) | $161.03 M(-12.7%) |
| Jan 2023 | - | $184.44 M(+28.3%) |
| Oct 2022 | - | $143.81 M(-12.6%) |
| July 2022 | - | $164.57 M(-11.1%) |
| Apr 2022 | - | $185.09 M(-11.0%) |
| Apr 2022 | $185.09 M(-28.0%) | - |
| Jan 2022 | - | $207.94 M(-8.6%) |
| Oct 2021 | - | $227.47 M(-6.9%) |
| July 2021 | - | $244.43 M(-5.0%) |
| Apr 2021 | $257.19 M(+207.1%) | $257.19 M(+339.2%) |
| Jan 2021 | - | $58.56 M(-9.9%) |
| Oct 2020 | - | $64.98 M(-12.7%) |
| July 2020 | - | $74.44 M(-11.1%) |
| Apr 2020 | $83.75 M(-13.4%) | $83.75 M(-6.7%) |
| Jan 2020 | - | $89.75 M(-8.2%) |
| Oct 2019 | - | $97.79 M(-4.0%) |
| July 2019 | - | $101.87 M(+5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2019 | $96.74 M(+255.0%) | $96.74 M(-7.0%) |
| Jan 2019 | - | $104.03 M(-2.7%) |
| Oct 2018 | - | $106.95 M(+307.4%) |
| July 2018 | - | $26.25 M(-3.7%) |
| Apr 2018 | $27.25 M(-13.0%) | $27.25 M(-4.6%) |
| Jan 2018 | - | $28.57 M(-8.1%) |
| Oct 2017 | - | $31.08 M(+16.3%) |
| July 2017 | - | $26.73 M(-14.7%) |
| Apr 2017 | $31.33 M(+45.7%) | $31.33 M(-10.1%) |
| Jan 2017 | - | $34.85 M(+2.7%) |
| Sept 2016 | - | $33.94 M(-5.8%) |
| June 2016 | - | $36.04 M(-16.3%) |
| Apr 2016 | $21.50 M(-56.4%) | - |
| Mar 2016 | - | $43.07 M(-12.7%) |
| Dec 2015 | $49.31 M(-211.6%) | $49.31 M(-9.7%) |
| Sept 2015 | - | $54.62 M(-7.9%) |
| June 2015 | - | $59.32 M(-221.1%) |
| Mar 2015 | - | -$48.97 M(+10.8%) |
| Dec 2014 | -$44.18 M(+31.1%) | -$44.18 M(+11.5%) |
| Sept 2014 | - | -$39.64 M(+17.6%) |
| Dec 2013 | -$33.71 M(+19.2%) | -$33.71 M |
| Dec 2012 | -$28.29 M | - |
FAQ
- What is KalVista Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual shareholders equity year-on-year change?
- What is KalVista Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly shareholders equity year-on-year change?
What is KalVista Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of KALV is $206.58 M
What is the all time high annual shareholders equity for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual stockholders equity is $257.19 M
What is KalVista Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, KALV annual stockholders equity has changed by +$45.56 M (+28.29%)
What is KalVista Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of KALV is $172.80 M
What is the all time high quarterly shareholders equity for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly stockholders equity is $257.19 M
What is KalVista Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, KALV quarterly stockholders equity has changed by +$58.35 M (+50.99%)